CY1687A - Bis-dimethoxymethyl(trimethoxybenzyl)isoquinolinium salts,their preparation and pharmaceutical compositions containing them - Google Patents

Bis-dimethoxymethyl(trimethoxybenzyl)isoquinolinium salts,their preparation and pharmaceutical compositions containing them

Info

Publication number
CY1687A
CY1687A CY1687A CY168793A CY1687A CY 1687 A CY1687 A CY 1687A CY 1687 A CY1687 A CY 1687A CY 168793 A CY168793 A CY 168793A CY 1687 A CY1687 A CY 1687A
Authority
CY
Cyprus
Prior art keywords
trimethoxybenzyl
dimethoxymethyl
bis
preparation
pharmaceutical compositions
Prior art date
Application number
CY1687A
Other languages
English (en)
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of CY1687A publication Critical patent/CY1687A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Jib Cranes (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Cephalosporin Compounds (AREA)
CY1687A 1984-07-18 1993-10-10 Bis-dimethoxymethyl(trimethoxybenzyl)isoquinolinium salts,their preparation and pharmaceutical compositions containing them CY1687A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
CY1687A true CY1687A (en) 1993-10-10

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1687A CY1687A (en) 1984-07-18 1993-10-10 Bis-dimethoxymethyl(trimethoxybenzyl)isoquinolinium salts,their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US4761418A (fi)
EP (1) EP0181055B1 (fi)
JP (1) JPH0662568B2 (fi)
AT (1) ATE60759T1 (fi)
AU (1) AU574481B2 (fi)
BG (1) BG60411B2 (fi)
CA (1) CA1273341A (fi)
CY (1) CY1687A (fi)
DD (1) DD235638A5 (fi)
DE (2) DE3581699D1 (fi)
DK (1) DK168093B1 (fi)
ES (1) ES8609260A1 (fi)
FI (1) FI85019C (fi)
GB (1) GB8418303D0 (fi)
GE (1) GEP19960468B (fi)
HK (1) HK47593A (fi)
HU (1) HU193996B (fi)
IE (1) IE58138B1 (fi)
IL (1) IL75833A (fi)
LT (1) LT2078B (fi)
LU (1) LU88801I2 (fi)
LV (1) LV5483A3 (fi)
MC (1) MC1690A1 (fi)
MX (1) MX9203667A (fi)
NL (1) NL940023I2 (fi)
NZ (1) NZ212766A (fi)
PL (1) PL146066B1 (fi)
SG (1) SG3493G (fi)
SU (1) SU1468414A3 (fi)
ZA (1) ZA855407B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
TR199902330T2 (xx) * 1997-03-25 2000-02-21 Glaxo Group Limited Ultra k�sa etkili n�rom�sk�ler blokerler olarak ikameli izokuinolinler.
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
EP1684753A2 (en) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
EP2101772B1 (en) * 2006-12-06 2012-04-25 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
EP2125742A2 (en) * 2007-03-08 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
EP2125743A1 (en) * 2007-03-26 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
EP2155684B1 (en) * 2007-05-01 2014-04-09 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
AU2008273724B2 (en) * 2007-05-01 2013-05-23 Chemagis Ltd. Process for Producing Cisatracurium and Associated Intermediates
CA2687157A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
AU2008320380A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
ITMI20080319A1 (it) * 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (zh) 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
WO2014005122A2 (en) * 2012-06-29 2014-01-03 Savarese John J Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
IL55254A (en) 1977-08-01 1983-03-31 Massachusetts Gen Hospital Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (en) 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
CA1178275A (en) * 1980-12-17 1984-11-20 David A. Yeowell Bis-isoquinolinium salts as long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
NL940023I2 (nl) 1998-06-02
JPH0662568B2 (ja) 1994-08-17
ZA855407B (en) 1986-04-30
ATE60759T1 (de) 1991-02-15
BG60411B2 (bg) 1995-02-28
DD235638A5 (de) 1986-05-14
SG3493G (en) 1993-03-12
MC1690A1 (fr) 1986-07-18
CA1273341A (en) 1990-08-28
HU193996B (en) 1987-12-28
GEP19960468B (en) 1996-08-29
US4761418A (en) 1988-08-02
PL146066B1 (en) 1988-12-31
IE58138B1 (en) 1993-07-14
DE19675039I2 (de) 2003-01-09
MX9203667A (es) 1992-07-31
DK168093B1 (da) 1994-02-07
EP0181055A1 (en) 1986-05-14
IL75833A0 (en) 1985-11-29
FI852807L (fi) 1986-01-19
LV5483A3 (lv) 1994-03-10
SU1468414A3 (ru) 1989-03-23
FI852807A0 (fi) 1985-07-17
DK324985A (da) 1986-01-19
AU4510885A (en) 1986-01-23
FI85019C (fi) 1992-02-25
PL254571A1 (en) 1986-07-15
AU574481B2 (en) 1988-07-07
HK47593A (en) 1993-05-21
EP0181055B1 (en) 1991-02-06
GB8418303D0 (en) 1984-08-22
DE3581699D1 (de) 1991-03-14
IE851791L (en) 1986-01-18
ES8609260A1 (es) 1986-09-01
HUT40626A (en) 1987-01-28
FI85019B (fi) 1991-11-15
LU88801I2 (fr) 1996-11-05
DK324985D0 (da) 1985-07-17
NL940023I1 (nl) 1995-01-02
JPS6187666A (ja) 1986-05-06
NZ212766A (en) 1988-03-30
LT2078B (lt) 1993-06-15
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30

Similar Documents

Publication Publication Date Title
SG3493G (en) Bis-dimethoxymethyl(trimethoxybenzyl)isoquinolinium salts,their preparation and pharmaceutical compositions containing them
NZ208831A (en) Imidazolium derivatives and pharmaceutical compositions
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
IL78691A0 (en) Quinolylglycinamide derivatives,their preparation and pharmaceutical compositions containing them
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL94693A0 (en) Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them
IL71860A0 (en) Substituted isoquinoline derivatives,their manufacture and pharmaceutical compositions containing them
IL69848A0 (en) 15-cycloaliphatic derivatives of 11,14-didehydrocarboprostacyclins,their preparation and pharmaceutical compositions containing them
IL69274A (en) (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
ZA8683B (en) Antihypertensive agents,pharmaceutical compositions containing them and process for the preparation of the agents and compositions